Clinical Trial Update: Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes [Phase 1]

View source ↗

Summary

Phase 1 exploratory study evaluating potential endocrine changes with sodium oxybate (Xyrem) in narcolepsy with cataplexy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy with Cataplexy

Drugs mentioned

• Sodium Oxybate (Sodium Oxybate)
• Xyrem (Sodium Oxybate)

Snippet

Sponsor: UCB Pharma SA | Conditions: Narcolepsy With Cataplexy | Phase 1 | Status: COMPLETED | Results posted: 2022-04-08